BICYCLOAMINE CARBOXAMIDE DERIVATIVE
The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof that has therapeutic and prophylactic effects on diseases in which orexin type 2 receptors participate, specifically, narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc. [In the formula: R1 and R2 independently represent a hydrogen atom, etc.; R3 and R4 independently represent a hydrogen atom, etc.; R5 represents optionally substituted C1-4 alkyl; -L1-ring G represents -ring G, -CH2-ring G, etc.; R6s independently represent a hydrogen atom, etc.; n is an integer of 1 or 2; ring G represents an optionally substituted C6-10 aromatic carbocyclic group, etc.; A1 represents an oxygen atom, etc.; A2 represents an oxygen atom, etc.; j, k, l and m are independently an integer of 0, 1 or 2; a broken line represents a single or double bond; X represents -CR7-, etc.; R7 represents a hydrogen atom, etc.; and ring E is represented by formula (1a-1), (1a-2) or (1a-3).].
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 26. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
FUNAKOSHI YUTA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-10-26, Last update posted on www.tib.eu: 2023-11-30, Last updated: 2023-12-08 |
|---|
| Patentnummer: |
WO2023204291 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA01840619X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA01840619X | ||
| 003 | DE-627 | ||
| 005 | 20231208114528.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231110s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA01840619X | ||
| 035 | |a (EPA)WO2023204291 | ||
| 035 | |a (EPA)88419943 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a FUNAKOSHI YUTA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a BICYCLOAMINE CARBOXAMIDE DERIVATIVE |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-10-26, Last update posted on www.tib.eu: 2023-11-30, Last updated: 2023-12-08 | ||
| 520 | |a The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof that has therapeutic and prophylactic effects on diseases in which orexin type 2 receptors participate, specifically, narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc. [In the formula: R1 and R2 independently represent a hydrogen atom, etc.; R3 and R4 independently represent a hydrogen atom, etc.; R5 represents optionally substituted C1-4 alkyl; -L1-ring G represents -ring G, -CH2-ring G, etc.; R6s independently represent a hydrogen atom, etc.; n is an integer of 1 or 2; ring G represents an optionally substituted C6-10 aromatic carbocyclic group, etc.; A1 represents an oxygen atom, etc.; A2 represents an oxygen atom, etc.; j, k, l and m are independently an integer of 0, 1 or 2; a broken line represents a single or double bond; X represents -CR7-, etc.; R7 represents a hydrogen atom, etc.; and ring E is represented by formula (1a-1), (1a-2) or (1a-3).] | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a IDEUE EIJI |4 aut | |
| 700 | 0 | |a SAKAMOTO KEITA |4 aut | |
| 700 | 0 | |a KOMIYA MASAFUMI |4 aut | |
| 700 | 0 | |a NAGAHAMA RIKO |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 26. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:26 |g month:10 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88419943/publication/WO2023204291A1?q=WO2023204291 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 26 |c 10 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 26 |c 10 | ||